This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and psychiatric disorders. Its structure, which includes a pyrrolidine ring and a fluorinated pyridine moiety, makes it valuable for designing compounds that interact with specific receptors in the brain, such as nicotinic acetylcholine receptors. Additionally, it is explored for its potential in creating drugs with improved selectivity and efficacy for treating conditions like Alzheimer's disease, depression, and anxiety. Its chiral nature also allows for the development of enantiomerically pure therapeutics, enhancing drug performance and reducing side effects.